432개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일
데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.
Multiple solid tumors · PD-1
HER2+ breast cancer, HER2+ gastric/GEJ adenocarcinoma · HER2
NSCLC, SCLC, HCC, TNBC, urothelial carcinoma, and others · PD-L1
HER2-positive breast cancer (including regimen-specific first-line and early-stage indications); HER2-low/ultralow brea… · HER2
Esophageal squamous cell carcinoma, gastric/GEJ adenocarcinoma, and first-line HER2-positive GEA with zanidatamab and c… · PD-1
Locally advanced or metastatic urothelial carcinoma · Nectin-4
First-line HER2-positive gastric, GEJ, or esophageal adenocarcinoma; previously treated HER2-positive biliary tract can… · HER2 (biparatopic)
CLDN18.2-positive HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma · CLDN18.2 (claudin-18.2)
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung · Solid Malignancies
Advanced Hepatocellular Carcinoma (HCC) · HER2
Solid Tumors · Solid Tumor, Adult
Hepatocellular Carcinoma · Muscle Invasive Bladder Cancer
Advanced Unresectable Hepatocellular Carcinoma · Hepatocellular Carcinoma
Advanced Solid Tumor · Advanced Solid Tumor
Breast Adenocarcinoma; Metastatic Breast Carcinoma · B-cell Lymphoma
Carcinoma, Non-Squamous Non-Small Cell Lung · PD-L1
Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma
Colorectal Cancer; Resectable Colorectal Carcinoma · Head and Neck Squamous Cell Carcinoma
1 / 22 pages
자동 수집 갱신 권장 · 9월 2일 · 방문 0 / 0